{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:07:20Z","timestamp":1791220040716,"version":"4.1.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.autrev.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T15:16:22Z","timestamp":1347981382000},"page":"523-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Emerging and critical issues in the pathogenesis of lupus"],"prefix":"10.1016","volume":"12","author":[{"given":"Mariele","family":"Gatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.09.003_bb0005","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2011.10.022","article-title":"Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?","volume":"11","author":"Costenbader","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","article-title":"SLE diagnosis and treatment: when early is early","volume":"10","author":"Doria","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1423.015","article-title":"A genome-wide study of lupus: preliminary analysis and data release","volume":"1110","author":"Cervino","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJMoa0707865","article-title":"Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX","volume":"358","author":"Hom","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ng.79","article-title":"Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus","volume":"40","author":"Kozyrev","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0045","doi-asserted-by":"crossref","first-page":"e1000841","DOI":"10.1371\/journal.pgen.1000841","article-title":"Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng.2007.47","article-title":"Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus","volume":"40","author":"Cunninghame Graham","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.coi.2010.09.002","article-title":"Recent findings on genetics of systemic autoimmune diseases","volume":"22","author":"Delgado-Vega","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0060","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/rheumatology\/ken247","article-title":"The genetics of SLE: an update in the light of genome-wide association studies","volume":"47","author":"Rhodes","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2012.09.003_bb0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/annrheumdis-2011-200808","article-title":"Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G","volume":"71","author":"Fernando","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0070","doi-asserted-by":"crossref","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","article-title":"Risk alleles for systemic lupus erythematosus in a large case\u2013control collection and associations with clinical subphenotypes","volume":"7","author":"Taylor","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2011.05.004","article-title":"Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR","volume":"37","author":"Fu","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.09.003_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009734.2011.624649","article-title":"The type I interferon system in the etiopathogenesis of autoimmune diseases","volume":"116","author":"R\u00f6nnblom","year":"2011","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0085","doi-asserted-by":"crossref","first-page":"948364","DOI":"10.1155\/2010\/948364","article-title":"Interferon alpha in systemic lupus erythematosus","volume":"2010","author":"Niewold","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/hmg\/ddm359","article-title":"Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 reveals a novel 5bp length polymorphism as strong risk factor for systemic lupus erythematosus","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0095","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.0701266104","article-title":"Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus","volume":"104","author":"Graham","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.09.003_bb0100","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/art.23613","article-title":"Association of the IRF5 risk haplotype with high serum interferon-a activity in systemic lupus erythematosus patients","volume":"58","author":"Niewold","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0110","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/ard.2008.097642","article-title":"STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk","volume":"68","author":"Abelson","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ng.200","article-title":"Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus","volume":"40","author":"Graham","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0120","first-page":"262","article-title":"Associations between the polymorphisms of TLR and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"30","author":"Lee","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ddr.20487","article-title":"Beyond transitional selection: new roles for BLyS in peripheral tolerance","volume":"72","author":"Oropallo","year":"2011","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0130","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/eji.201041014","article-title":"Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs","volume":"41","author":"Hackl","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","article-title":"TLR7 and TLR9 in SLE: when sensing self goes wrong","volume":"53","author":"Celhar","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0140","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2382","article-title":"Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus","volume":"10","author":"Kwok","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.09.003_bb0145","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/ard.2010.144485","article-title":"Safety profile and clinical activity of sifalimumab, a fully human anti-interferon \u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study","volume":"70","author":"Merril","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0150","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08916930701510848","article-title":"PTPN22: its role in SLE and autoimmunity","volume":"40","author":"Chung","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05132.x","article-title":"FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus","volume":"1183","author":"Niederer","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0160","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ng2046","article-title":"FCGR3B copy number variation is associated with susceptibility to systemic, but not organ specific, autoimmunity","volume":"39","author":"Fanciulli","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxm002","article-title":"Follicular exclusion of autoreactive B cells requires FcgammaRIIb","volume":"19","author":"Paul","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0175","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1288","article-title":"Loss of function of a lupus associated FcgammaRIIb polymorphism through exclusion from lipid rafts","volume":"11","author":"Floto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0180","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.24360","article-title":"Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus","volume":"60","author":"Webb","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0185","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.4049\/jimmunol.179.9.6352","article-title":"Demethylation of CD40LG on the inactive Z in T cells from women with lupus","volume":"179","author":"Lu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0190","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/ard.2011.154104","article-title":"Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus","volume":"70","author":"Sanchez","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI118552","article-title":"Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans","volume":"97","author":"Salmon","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.09.003_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2006.03141.x","article-title":"CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus","volume":"145","author":"Patschan","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1523-1755.2005.00436.x","article-title":"CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms","volume":"68","author":"Odobasic","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2012.09.003_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2302\/kjm.60.10","article-title":"Epigenetics and autoimmunity, with special emphasis on methylation","volume":"60","author":"Renaudineau","year":"2011","journal-title":"Keio J Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0215","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.molmed.2011.07.005","article-title":"Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases","volume":"17","author":"Hedrich","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2010.05831.x","article-title":"Epigenetics in lupus","volume":"1217","author":"Zouali","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0225","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.4049\/jimmunol.179.8.5553","article-title":"Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus","volume":"179","author":"Gorelik","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.rdc.2004.04.001","article-title":"Nucleosomes in the pathogenesis of systemic lupus erythematosus","volume":"30","author":"Koutouzov","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2012.09.003_bb0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrrheum.2011.16","article-title":"Epigenetic alterations in autoimmune rheumatic diseases","volume":"7","author":"Ballestar","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissi\u00e8re","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2119\/molmed.2011.00055","article-title":"HDAC inhibition in lupus models","volume":"17","author":"Reilly","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0250","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10160","article-title":"Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling","volume":"85","author":"Nambiar","year":"2002","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2012.09.003_bb0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2012.04.005","article-title":"miRNA in systemic lupus erythematosus","volume":"144","author":"Amarilyo","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0260","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0265","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.coi.2008.08.003","article-title":"Role of B cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"20","author":"Mandik-Nayak","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.09.003_bb0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2007.12.003","article-title":"How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype","volume":"29","author":"Crispin","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.autrev.2008.07.040","article-title":"Altered T, and B lymphocyte signaling pathways in lupus","volume":"8","author":"Peng","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0285","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/art.30353","article-title":"Calcium signaling in systemic lupus erythematosus T cells: a treatment target","volume":"63","author":"Kyttaris","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0290","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.smim.2006.03.011","article-title":"Autoimmunity in systemic lupus erythematosus: integrating genes and biology","volume":"18","author":"Krishnan","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0295","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","article-title":"Human TCR-alpha beta+ CD4\u2212 CD8\u2212 T cells can derive from CD8+ T cells and display an inflammatory effector phenotype","volume":"183","author":"Crispin","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0300","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2008.07.047","article-title":"Altered B cell receptor signaling in human systemic lupus erythematosus","volume":"8","author":"Jenks","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0305","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1002\/art.21416","article-title":"Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus","volume":"52","author":"Flores-Borja","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.22309","article-title":"Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus","volume":"56","author":"Flores-Borja","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0315","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/eji.201141940","article-title":"Lyn deficiency affects B-cell maturation as well as survival","volume":"42","author":"Shahaf","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0320","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ni.2246","article-title":"Protein tyrosine phosphatases in lymphocyte activation and autoimmunity","volume":"13","author":"Rhee","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar3433","article-title":"Mechanisms of B cell autoimmunity in SLE","volume":"13","author":"D\u00f6rner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.09.003_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00441-010-1031-3","article-title":"Modulation of B cell responses by Toll-like receptors","volume":"343","author":"Booth","year":"2011","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0335","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0340","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ncomms1769","article-title":"BCR-signaling synergizes with TLR-signaling for induction of AID and immunoglobulin class-switching through the non-canonical NF-\u03baB pathway","volume":"3","author":"Pone","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2012.09.003_bb0345","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0350","first-page":"89","article-title":"Mitochondrial regulation of apoptosis","volume":"18","author":"Mayer","year":"2003","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0355","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.4049\/jimmunol.167.10.5963","article-title":"Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells","volume":"167","author":"Shoshan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0360","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.58.5.309","article-title":"Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia","volume":"58","author":"Courtney","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cellimm.2005.08.031","article-title":"The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus","volume":"235","author":"Whang","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cellimm.2006.05.003","article-title":"Abnormal Fas\/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus","volume":"239","author":"Xue","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10067-004-0972-x","article-title":"Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus","volume":"24","author":"Jin","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.03.004","article-title":"Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus","author":"Chen","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0385","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00296-009-0933-4","article-title":"Increased expression of CD154 and FAS in SLE patients' lymphocytes","volume":"30","author":"Manea","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.09.003_bb0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10067-011-1821-3","article-title":"The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus","volume":"31","author":"Rastin","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/08916934.2010.536794","article-title":"Regulatory and pathogenetic mechanisms of autoantibodies in SLE","volume":"44","author":"Radic","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0400","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","article-title":"Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players","volume":"15","author":"Kruse","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar2966","article-title":"The role of dendritic cells in the pathogenesis of systemic lupus erythematosus","volume":"12","author":"Fransen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.09.003_bb0415","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1189\/jlb.0709517","article-title":"Infections and autoimmunity: the multifaceted relationship","volume":"87","author":"Sfriso","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12026-010-8184-8","article-title":"Microparticles as a source of extracellular DNA","volume":"49","author":"Pisetsky","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0425","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrrheum.2010.66","article-title":"Microparticles as autoadjuvants in the pathogenesis of SLE","volume":"6","author":"Pisetsky","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/08916930903510930","article-title":"IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE","volume":"43","author":"Munoz","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0435","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","article-title":"NETs: a new strategy for using old weapons","volume":"30","author":"Papayannopoulos","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0440","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0445","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1056\/NEJMcibr1107085","article-title":"Systemic lupus erythematosus and the neutrophil","volume":"365","author":"Bosch","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0450","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0455","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0460","doi-asserted-by":"crossref","first-page":"715190","DOI":"10.1155\/2012\/715190","article-title":"Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus","volume":"2012","author":"Yu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0465","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0470","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2010.07.015","article-title":"Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity","volume":"10","author":"Torres-Aguilar","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0475","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.09.003_bb0480","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar3075","article-title":"Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"12","author":"Jin","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.09.003_bb0485","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0490","doi-asserted-by":"crossref","first-page":"e32001","DOI":"10.1371\/journal.pone.0032001","article-title":"Two major autoantibody clusters in systemic lupus erythematosus","volume":"7","author":"Ching","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2012.09.003_bb0495","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0500","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.coi.2010.08.001","article-title":"B-cell tolerance: mechanisms and implications","volume":"22","author":"Basten","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0505","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI38010","article-title":"The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus","volume":"119","author":"Cancro","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.09.003_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2008.07.014","article-title":"Infections rheumatism and autoimmunity. the conflicting relationship between humans and their environment","volume":"8","author":"Doria","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2008.07.019","article-title":"Infections as triggers and complications of systemic lupus erythematosus","volume":"8","author":"Doria","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0520","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0961203311426568","article-title":"Environment and lupus-related diseases","volume":"21","author":"Zandman-Goddard","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2012.09.003_bb0525","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/08916930500285394","article-title":"Environment and systemic lupus erythematosus: an overview","volume":"38","author":"Sarzi-Puttini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0530","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1073\/pnas.1102600108","article-title":"Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans","volume":"108","author":"Meyers","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.09.003_bb0535","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.175.8.5067","article-title":"Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens","volume":"175","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0540","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mckay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0545","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3899\/jrheum.100214","article-title":"Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus","volume":"38","author":"Landolt-Marticorena","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0550","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/art.23678","article-title":"Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus","volume":"58","author":"Petri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0555","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0560","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.09.003_bb0565","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.01.005","article-title":"Human T cells induce their own regulation through activation of B cells","volume":"36","author":"Lemoine","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.09.003_bb0570","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrrheum.2010.140","article-title":"Regulatory B cells in autoimmunity: developments and controversies","volume":"6","author":"Mauri","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0575","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0580","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0585","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0590","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0595","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4(+) T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0600","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/labinvest.3700497","article-title":"Lupus resistance is associated with marginal zone abnormalities an NZM murine model","volume":"87","author":"Duan","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2012.09.003_bb0610","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/jaut.2001.0514","article-title":"Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: clues to their origin","volume":"16","author":"Sharma","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.09.003_bb0615","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0620","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0625","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/eji.201041315","article-title":"High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB\/W F1 lupus mice","volume":"41","author":"Starke","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0630","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0635","first-page":"1538","article-title":"Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies","volume":"33","author":"Guti\u00e9rrez-Adrianz\u00e9n","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0640","first-page":"50","article-title":"Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study","volume":"29","author":"Ghirardello","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0645","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ncprheum0899","article-title":"Primary prevention of systemic lupus erythematosus","volume":"4","author":"Doria","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.07.002","article-title":"Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis","author":"Bizzaro","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0655","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2003.12.005","article-title":"Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients","volume":"22","author":"Ghirardello","year":"2004","journal-title":"J Autoimmun."},{"key":"10.1016\/j.autrev.2012.09.003_bb0660","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2012.02728.x","article-title":"Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification","author":"Pisetsky","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0665","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrrheum.2010.56","article-title":"Are anti-C1q antibodies different from other SLE autoantibodies?","volume":"6","author":"Pickering","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0670","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2009.04746.x","article-title":"Anti-C1q autoantibodies in lupus nephritis","volume":"1173","author":"Sinico","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0675","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/03009740701218717","article-title":"Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases","volume":"36","author":"Braun","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0680","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0685","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0690","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","article-title":"Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study","volume":"32","author":"Briani","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.09.003_bb0695","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0961203309353914","article-title":"Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies","volume":"19","author":"Ghirardello","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2012.09.003_bb0700","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jaut.2002.0595","article-title":"Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays","volume":"19","author":"Ghirardello","year":"2002","journal-title":"J Autoimmun."},{"key":"10.1016\/j.autrev.2012.09.003_bb0705","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/ard.59.12.975","article-title":"Anti ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with the IgG anticardiolipin antibodies","volume":"59","author":"Ghirardello","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0710","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0715","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0720","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.09.003_bb0725","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0730","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0735","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s000180300050","article-title":"Recombinant anti-P proteins autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition","volume":"60","author":"Zampieri","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0740","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0745","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/ard.60.1.72","article-title":"Dephosphorylation of autoantigenic ribosomal P proteins during FAS-L induced apoptosis; a possible trigger for the development of the autoimmune response in SLE patients","volume":"60","author":"Zampieri","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0750","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autrev.2006.07.002","article-title":"To smell the immune system: olfaction, autoimmunity and brain involvement","volume":"6","author":"Strous","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.09.003_bb0755","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24491","article-title":"The sense of smell in systemic lupus erythematosus","volume":"60","author":"Shoenfeld","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0760","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0765","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2010.05.038","article-title":"Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood\u2013brain barrier breakdown","volume":"1345","author":"Levin","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2012.09.003_bb0770","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"van Bavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.09.003_bb0775","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.ki.5002133","article-title":"Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis","volume":"71","author":"Kaalaji","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2012.09.003_bb0780","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0961203309106175","article-title":"Renal cell apoptosis in human lupus nephritis: a histological study","volume":"18","author":"Faurschou","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2012.09.003_bb0785","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08916930802375729","article-title":"Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice","volume":"42","author":"Mjelle","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.09.003_bb0790","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1422.025","article-title":"Autoantibodies against protective molecules\u2014C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus","volume":"1108","author":"Shoenfeld","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.09.003_bb0795","first-page":"1980","article-title":"Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"33","author":"Figueredo","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0800","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coi.2008.05.004","article-title":"Pentraxins, humoral innate immunity and tissue injury","volume":"20","author":"Manfredi","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0805","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.09.003_bb0810","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","article-title":"Human renal epithelial cells produce the long pentraxin PTX3","volume":"67","author":"Nauta","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2012.09.003_bb0815","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2012.09.003_bb0820","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.09.003_bb0825","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.09.003_bb0830","unstructured":"Doria A, Gatto M. Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. Lupus in press."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:54:44Z","timestamp":1594670084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":166,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1568997212002133"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.09.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging and critical issues in the pathogenesis of lupus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2012.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}